Athos Capital LTD Hutchmed (China) LTD Transaction History

Athos Capital LTD

  • $311 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020
SELL
$17.17 - $25.95 $1.47 Million - $2.23 Million
-85,815 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$17.84 - $22.69 $491,402 - $624,996
27,545 Added 47.27%
85,815 $1.53 Million
Q2 2019

Aug 13, 2019
BUY
$22.0 - $31.78 $1.28 Million - $1.85 Million
58,270 New
58,270 $1.28 Million

Others Institutions Holding HCM

# of Institutions
65
Shares Held
6.88M
Call Options Held
6.2K
Put Options Held
1.1K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.19B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Athos Capital LTD Portfolio

Follow Athos Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athos Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Athos Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email